Ordinary Re-Weighting | DER AKTIONÄR BIOTECH SUPERTRENDS INDEX | Effective Date 2nd October 2024
DER AKTIONÄR BIOTECH SUPERTRENDS INDEX:
In the ordinary re-weighting, the following composition will be implemented effective open 2nd October 2024:
| ARROWHEAD PHARMACEUTICALS INC |
| BIONTECH SE |
| BLUEPRINT MEDICINES CORP |
| CRISPR THERAPEUTICS AG |
| DENALI THERAPEUTICS INC |
| ECKERT & ZIEGLER STRAHLEN UND MEDIZINTECHNIK AG |
| ILLUMINA INC |
| IMMUNOCORE HOLDINGS PLC |
| INTUITIVE SURGICAL INC |
| MADRIGAL PHARMACEUTICALS INC |
| SWEDISH ORPHAN BIOVITRUM AB |
| VIKING THERAPEUTICS INC |
| VOYAGER THERAPEUTICS INC |